CYCS
Cytochrome c
Also known as: CYC, CYC_HUMAN, HCS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P99999
- Gene
- CYCS
- Ensembl
- ENSG00000172115
- Chromosome
- 7
- Canonical length
- 105 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a small heme protein that functions as a central component of the electron transport chain in mitochondria. The encoded protein associates with the inner membrane of the mitochondrion where it accepts electrons from cytochrome b and transfers them to the cytochrome oxidase complex. This protein is also involved in initiation of apoptosis. Mutations in this gene are associated with autosomal dominant nonsyndromic thrombocytopenia. Numerous processed pseudogenes of this gene are found throughout the human genome.[provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
105 residues, UniProt reviewed canonical sequence.
>P99999|CYCS
1 MGDVEKGKKI FIMKCSQCHT VEKGGKHKTG PNLHGLFGRK TGQAPGYSYT AANKNKGIIW
61 GEDTLMEYLE NPKKYIPGTK MIFVGIKKKE ERADLIAYLK KATNELocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYCS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 747 nTPM
Expression across tissuesHPA
Tissue
- tongue: 747 nTPM
- skeletal muscle: 453 nTPM
- heart muscle: 446 nTPM
- colon: 247 nTPM
- rectum: 224 nTPM
- parathyroid gland: 212 nTPM
Single-cell type
- parietal cells: 2,035 nCPM
- esophageal suprabasal cells: 1,229 nCPM
- colonocytes: 1,029 nCPM
- esophageal apical cells: 960 nCPM
- vascular smooth muscle cells: 951 nCPM
- esophageal basal cells: 826 nCPM
Immune cell
- intermediate monocyte: 106 nTPM
- myeloid DC: 106 nTPM
- memory B-cell: 103 nTPM
- non-classical monocyte: 97 nTPM
- naive B-cell: 91 nTPM
- T-reg: 88 nTPM
Brain region
- cerebral cortex: 147 nTPM
- choroid plexus: 122 nTPM
- thalamus: 111 nTPM
- hypothalamus: 111 nTPM
- cerebellum: 104 nTPM
- midbrain: 90 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CYCS.
Disease | AllUniProt
Conditions CYCS is implicated in, by any mechanism.
- Thrombocytopenia 4 (THC4) MIM:612004
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 59 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Thrombocytopenia 4
- Thrombocytopenia
ReferencesPubMed · IEDB
Publications for CYCS from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
4 publications
- Topographic determinants on cytochrome c. I. The complete antigenic structures of rabbit, mouse, and guanaco cytochromes c in rabbits and mice1.
1977 · J Immunol · RCR 2.4 · 100 citations - The specificity of human anti-cytochrome c autoantibodies that arise in autoimmune disease.
1990 · J Immunol · RCR 0.6 · 29 citations - Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects.
2019 · Int J Chron Obstruct Pulmon Dis · RCR 0.5 · 13 citations - Circulating autoantibodies to hidden mitochondrial antigenic determinants in mammals.
1981 · Ann Allergy
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0.64
- gnomAD missense Z
- 1.18
- DepMap mean gene effect
- -0.71
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic signaling pathway
- cellular respiration
- execution phase of apoptosis
- intrinsic apoptotic signaling pathway
- mitochondrial electron transport, cytochrome c to oxygen
- mitochondrial electron transport, ubiquinol to cytochrome c
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cytochrome c-like domain superfamily
- Cytochrome c, class IA/ IB
- Cytochrome c-like domain
- Cytochrome c
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CYCS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYCS as an antibody target. Whether an autoantibody or antibody against CYCS could matter depends on whether native CYCS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYCS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYCS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...